Gene silencing by diverse noncoding RNAs, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), is an integral aspect of eukaryotic gene regulation, host defense, and genome surveillance. miRNAs and siRNAs bind to specific mRNAs through complementary base pairing, leading to translation inhibition and accelerated RNA decay. Noncoding RNAs also direct heterochromatin formation in a sequence-specific manner, causing selective transcriptional silencing. 1, 2 The dynamic response of gene expression to changes in cellular state is a function of qualitative and quantitative changes in the miRNA and (endo)siRNA populations. 3, 4 While transcriptional control mechanisms are of key importance, much attention also is being paid on the ribonucleases that establish the maturation pathways, and how the RNAs are accurately generated from precursors in a regulated manner.
The RNase III family enzyme Dicer precisely cleaves the immediate precursors of miRNAs and siRNAs to directly provide the mature forms. 5, 6 Dicer works in association with other proteins, such as the mammalian double-stranded RNA (dsRNA)binding proteins TRBP and PACT. 7 However, it is now evident, through recent studies summarized below, that Dicer is inherently quite capable of the selective recognition and accurate processing of structurally diverse precursors. The molecular talents of Dicer reflect the specific interactions of the multiple domains of the polypeptide. The dsRNAspecific RNase III domain-the core catalytic element and defining feature of RNase III family members-is created through intramolecular association of tandem domains (RIIIa, RIIIb), forming a pseudodimeric structure that contains the catalytic center. On the N-terminal side is the PAZ domain that selectively recognizes the 2-nt, 3′-overhang structures, created by the prior action of Dicer on dsRNA, or of Drosha (another RNase III family member) on pri-miRNAs. A domain of unknown function (DUF283) is followed by an ATPase/helicase (ATP/hel) domain that also is the N-terminal structure. On the C-terminal side of the RNase III domain, and completing the~230-kDa polypeptide, is a dsRNA-binding domain (dsRBD)-a conserved fold present in most RNase III family members and in many other dsRNA-binding proteins.
Fundamental aspects of miRNA and siRNA processing have been productively analyzed using Dicer from diverse organisms. Dicer of Giardia intestinalis, composed of the PAZ-IIIa-IIIb triumvirate, yielded the first structural insight on how siRNA length is established through cooperation of the PAZ and RNase III domains. 8 Establishing a high-resolution structure-function profile of Human Dicer (hDcr) has been of particular interest, particularly with respect to human health, given the altered miRNA profiles of cancer cells 3 and that hDcr haploinsufficiency or specific mutation also is implicated in certain cancers. 9,10 However, hDcr has been a continuing challenge for structural and biochemical analyses, as it is particularly refractory towards purification in the needed amounts. Doudna et al. have provided a major step forward in our understanding of hDcr by separately expressing the domains in bacterial cells, and then testing the domains individually and in combination for catalytic activity and other behaviors. 11 Through this approach, new light has been shed on several enigmatic yet key structural features. First, limited proteolytic cleavage was used to identify boundaries of domains that then were separately expressed in and purified from bacterial cells. The RNase III domain with attached dsRBD was active, but produced 15-bp dsRNAs rather than the normal 22-bp products. While this behavior is reminiscent of bacterial RNase III action, inclusion of the purified DUF-PAZ domain re-established the characteristic 22-bp product length, providing biochemical confirmation of the crystallographic evidence 8 that the PAZ and RNase III domains together provide the sizing mechanism.
The dsRBD posed continuing questions as to its function, since the domain is not strictly conserved, and that its selective removal does not strongly affect hDcr activity in vitro. 12 However, Doudna et al. showed that the dsRBD is required for substrate binding and cleavage in the absence of the PAZ domain. 11 This finding, along with the previous demonstration of the functional requirement for the dsRBD of an engineered (intermolecular) dimeric form of the hDcr RNase IIIb domain, 13 shows that the hDcr dsRBD is functional in RNA recognition, although it cannot replace the PAZ domain in providing correctly sized products. With the question of inherent functionality of the hDcr dsRBD answered, the focus now can shift to identifying substrates that are processed by hDcr in a dsRBDdependent manner.
The N-terminal ATP/hel domain also is slow to reveal its functions. The ATP/hel domain has an inhibitory effect on the processing of siRNA precursors, in that its removal allowed cleavage of pre-siRNAs with comparable efficiency as seen with pre-miRNAs. 14 Using a bacterially expressed fusion protein, it was shown that the ATP/hel domain preferentially recognizes the loop structures of pre-miRNA. 11 The authors propose a "gatekeeper" function in conferring regulated access of RNA to the catalytic portion of hDcr. An interaction of TRBP with this domain 11 also supports a regulated access mechanism. Having a domain with a gatekeeper function is perhaps not unexpected, as ribonucleases operate in RNA-rich environments, and an otherwise uncontrolled access of RNA to a nuclease active site could be detrimental to the cell.
Ten years after the first descriptions of the basic biochemical behavior of recombinant hDcr, 15, 16 we are now witnessing a convergence of experimental approaches including, inter alia, electron microscopy of modified hDcr 17 and in vivo structure-function analysis of hDcr mutants 18 that reveals the structural basis for hDcr function. The ability to study hDcr through reassembled domains largely circumvents the difficulties in working with full-length protein and is expected to set the stage for biochemical and high-resolution structural studies on the protein-protein and RNA-protein interactions that establish the regulated maturation of mammalian miRNAs and siRNAs. In turn, an understanding of the interactions of hDcr with factors such as TRBP and PACT will allow full appreciation of a dynamic cellular nexus of dsRNAdependent transactions that underlie mammalian posttranscriptional regulation.
